CRVO William Robert Elder buys $36K worth of shares
May 15, 2025, 10:35 AM
0.00%
What does CRVO do
CervoMed, a Boston-based biotechnology company with 8 employees, focuses on developing neflamapimod for neurodegenerative diseases and is conducting the RewinD-LB Phase 2b trial for dementia with Lewy bodies. The drug aims to modify disease processes and improve synaptic dysfunction.
William Robert Elder bought 4,233 shares of CRVO on 14 May at $8.46 per share, worth a total of $36K. They now own 5,500 CRVO shares, or a 334% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.